SCM
IRMD icon

Semanteon Capital Management’s iRadimed IRMD Stock Holding History

Semanteon Capital Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,407
Closed -$284K – 183
2025
Q1 		$284K Buy
+5,407
New +$304K 0.15% 198
2024
Q4 		– Sell
-6,576
Closed -$331K – 283
2024
Q3 		$331K Buy
+6,576
New +$303K 0.23% 162

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Semanteon Capital Management's IRMD Position: Q2 2025 in Review

Semanteon Capital Management sold out of iRadimed (IRMD) in Q2 2025, closing a stake of 5,407 shares — an estimated $284K sold.

Semanteon Capital Management first reported a position in IRMD in Q3 2024 and held it in 2 quarters. The position peaked at $331K in Q3 2024. 162 funds tracked by Wall St. Rank hold IRMD as of Q2 2025.

  • Semanteon Capital Management reported no remaining iRadimed position as of Q2 2025 after selling out during the quarter.
  • Semanteon Capital Management sold 5,407 iRadimed shares in Q2 2025, an estimated $284K.
  • Semanteon Capital Management first reported a position in iRadimed in Q3 2024 and held it in 2 quarters.
  • Semanteon Capital Management's iRadimed position peaked at $331K in Q3 2024.
  • 162 funds tracked by Wall St. Rank held iRadimed as of Q2 2025.

Based on Semanteon Capital Management's 13F filing for Q2 2025, filed 11 Aug 2025.